5-methylcytidine has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breckpot, K; De Smedt, SC; Descamps, B; Dewitte, H; Lentacker, I; Van Bockstal, M; Vanhove, C; Verbeke, R; Wayteck, L | 1 |
| Arlt, VM; Kliem, C; Krais, AM; Schmeiser, HH | 1 |
| Blanco, S; Frye, M; Popis, MC | 1 |
| Strong, LC | 1 |
2 review(s) available for 5-methylcytidine and Benign Neoplasms
| Article | Year |
|---|---|
Posttranscriptional methylation of transfer and ribosomal RNA in stress response pathways, cell differentiation, and cancer.
Topics: Cell Differentiation; Cytidine; Cytosine; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Ribosomal; Stress, Physiological | 2016 |
The nature of cancer and the mechanisms of its control: a review.
Topics: Animals; Cytidine; DNA; Female; Humans; Liver; Mammary Tumor Virus, Mouse; Maternal Age; Mice; Mutation; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Nucleic Acid Conformation; Transplantation, Homologous | 1980 |
2 other study(ies) available for 5-methylcytidine and Benign Neoplasms
| Article | Year |
|---|---|
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA.
Topics: Animals; Cancer Vaccines; Cytidine; Dendritic Cells; Female; Immunotherapy; Lipid A; Lipids; Mice, Inbred C57BL; Neoplasms; RNA, Messenger; Toll-Like Receptors | 2017 |
Determination of genomic N3-methylthymidine in human cancer cells treated with nitrosamines using capillary electrophoresis with laser-induced fluorescence.
Topics: A549 Cells; Cytidine; Electrophoresis, Capillary; Fluorescence; Humans; Neoplasms; Nitrosamines; Thymidine | 2019 |